Ranking for CW22 2020

Ranking for CW22 / 2020 / Preview. This Tuesday, at the time of the ranking, the SPX was trading barely above the 200 day moving average. However, it closed slightly below the MA. Had the ranking been updated on Monday, no trades would have been necessary (allowed, that is). Since it was the S&P 500’s first day >200MA after the March correction, I decided

not to go “all-in” but only for about 50%. Should it be able to hold the 200MA until next week, I will keep adding. Still quite a few trades were done this week:

• Bought:

  • ADSK (Autodesk Inc. (S&P 500))
  • AMED (Amedisys (S&P 400))
  • AMZN (Amazon.com, Inc. (S&P 500))
  • ATVI (Activision Blizzard, Inc. (S&P 500))
  • BIO (Bio-Rad Laboratories, Inc. (S&P 400))
  • CIEN (Ciena Corporation (S&P 400))
  • CLX (The Clorox Company (S&P 500))
  • DG (Dollar General Corporation (S&P 500))
  • INCY (Incyte Corporation (S&P 500))
  • JKHY (Jack Henry & Associates, Inc. (S&P 500))
  • MASI (Masimo Corporation (S&P 400))
  • NFLX (Netflix, Inc. (S&P 500))
  • QLYS (Qualys, Inc. (Barrons 400))
  • REGN (Regeneron Pharmaceuticals, Inc. (S&P 500))
  • RGEN (Repligen Corporation (S&P 400))
  • SAM (The Boston Beer Company, Inc. (S&P 400))
  • SLP (Simulations Plus, Inc. (Barrons 400))
  • TECH (Bio-Techne Corporation (S&P 400))
  • UTHR (United Therapeutics Corporation (S&P 400))
  • VEEV (Veeva Systems Inc. (Barrons 400))
  • VRTX (Vertex Pharmaceuticals Incorporated (S&P 500))
  • WMT (Walmart Inc. (S&P 500))
  • WST (West Pharmaceutical Services, Inc. (S&P 400))

Current portfolio:

Sector distribution:

Index distribution:

Until next week!